{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:38:08Z","timestamp":1790253488203,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institutes of Health (NIH) AIDS Research and Reference Reagent"},{"name":"National Key Research and Development Plan of China","award":["2016YFC1200904"],"award-info":[{"award-number":["2016YFC1200904"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.vaccine.2017.10.007","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T17:41:49Z","timestamp":1507830109000},"page":"6387-6394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Development and application of a bioluminescent imaging mouse model for Chikungunya virus based on pseudovirus system"],"prefix":"10.1016","volume":"35","author":[{"given":"Jiajing","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.10.007_b0005","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0035-9203(55)90080-8","article-title":"An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952\u201353. I. Clinical features","volume":"49","author":"Robinson","year":"1955","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.10.007_b0010","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrmicro2368","article-title":"Biology and pathogenesis of Chikungunya virus","volume":"8","author":"Schwartz","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2017.10.007_b0015","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1099\/vir.0.82858-0","article-title":"Changing patterns of Chikungunya virus: re-emergence of a zoonotic arbovirus","volume":"88","author":"Powers","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2017.10.007_b0020","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nrrheum.2012.64","article-title":"Arthritogenic alphaviruses\u2013an overview","volume":"8","author":"Suhrbier","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.vaccine.2017.10.007_b0025","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1086\/517537","article-title":"Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients","volume":"44","author":"Borgherini","year":"2007","journal-title":"Clin Inf Dis: Off Publ Inf Dis Soc Am"},{"key":"10.1016\/j.vaccine.2017.10.007_b0030","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/S0140-6736(07)61779-6","article-title":"Infection with Chikungunya virus in Italy: an outbreak in a temperate region","volume":"370","author":"Rezza","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.10.007_b0035","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1371\/journal.pmed.0030263","article-title":"Genome microevolution of Chikungunya viruses causing the Indian Ocean outbreak","volume":"3","author":"Schuffenecker","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2017.10.007_b0040","first-page":"94","article-title":"Chikungunya virus infections","volume":"373","author":"Weaver","year":"2015","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2017.10.007_b0045","doi-asserted-by":"crossref","first-page":"7178","DOI":"10.1016\/j.vaccine.2009.09.024","article-title":"A robust lentiviral pseudotype neutralisation assay for in-field serosurveillance of rabies and lyssaviruses in Africa","volume":"27","author":"Wright","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.007_b0050","doi-asserted-by":"crossref","first-page":"30","DOI":"10.12688\/f1000research.6085.1","article-title":"Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry","volume":"4","author":"Long","year":"2015","journal-title":"F1000Research"},{"key":"10.1016\/j.vaccine.2017.10.007_b0055","doi-asserted-by":"crossref","first-page":"10473","DOI":"10.1073\/pnas.1510199112","article-title":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus","volume":"112","author":"Corti","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.10.007_b0060","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1128\/JVI.72.5.3539-3546.1998","article-title":"Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus","volume":"72","author":"Lagging","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.10.007_b0065","doi-asserted-by":"crossref","first-page":"42769","DOI":"10.1038\/srep42769","article-title":"Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system","volume":"7","author":"Nie","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2017.10.007_b0070","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature09555","article-title":"Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography","volume":"468","author":"Voss","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2017.10.007_b0075","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jviromet.2012.07.011","article-title":"Optimization and proficiency testing of a pseudovirus-based assay for detection of HIV-1 neutralizing antibody in China","volume":"185","author":"Nie","year":"2012","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2017.10.007_b0080","doi-asserted-by":"crossref","first-page":"10108","DOI":"10.1128\/JVI.79.16.10108-10125.2005","article-title":"Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies","volume":"79","author":"Li","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.10.007_b0085","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/QAI.0b013e3181663967","article-title":"Genetic and neutralization properties of HIV-1 env clones from subtype B\/BC\/AE infections in China","volume":"47","author":"Chong","year":"2008","journal-title":"J Acq Immun Def Synd"},{"key":"10.1016\/j.vaccine.2017.10.007_b0090","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1080\/21645515.2017.1325050","article-title":"A bioluminescent imaging mouse model for Marburg virus based on a pseudovirus system","volume":"13","author":"Zhang","year":"2017","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2017.10.007_b0095","doi-asserted-by":"crossref","first-page":"e928","DOI":"10.1371\/journal.pntd.0000928","article-title":"A DNA vaccine against Chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates","volume":"5","author":"Mallilankaraman","year":"2011","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.vaccine.2017.10.007_b0100","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1086\/605496","article-title":"Chikungunya fever: an epidemiological review of a re-emerging infectious disease","volume":"49","author":"Staples","year":"2009","journal-title":"Clin Inf Dis: Off Publ Inf Dis Soc Am"},{"key":"10.1016\/j.vaccine.2017.10.007_b0105","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1016\/j.vaccine.2017.07.101","article-title":"An LASV GPC pseudotyped virus based reporter system enables evaluation of vaccines in mice under non-BSL-4 conditions","volume":"35","author":"Li","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.007_b0110","doi-asserted-by":"crossref","first-page":"45552","DOI":"10.1038\/srep45552","article-title":"Antibody-dependent-cellular-cytotoxicity-inducing antibodies significantly affect the post-exposure treatment of Ebola virus infection","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2017.10.007_b0115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4269\/ajtmh.2008.79.133","article-title":"An animal model for studying the pathogenesis of Chikungunya virus infection","volume":"79","author":"Ziegler","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.10.007_b0120","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1371\/journal.ppat.0040029","article-title":"A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease","volume":"4","author":"Couderc","year":"2008","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.vaccine.2017.10.007_b0125","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1089\/vbz.2011.0648","article-title":"In vivo imaging of Chikungunya virus in mice and Aedes mosquitoes using a Renilla luciferase clone","volume":"11","author":"Ziegler","year":"2011","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.vaccine.2017.10.007_b0130","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1172\/JCI40104","article-title":"Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages","volume":"120","author":"Labadie","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2017.10.007_b0135","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.4049\/jimmunol.0904181","article-title":"Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response","volume":"184","author":"Her","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.10.007_b0140","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.vaccine.2015.10.106","article-title":"The efficacy of a novel vaccine approach using tumor cells that ectopically express a codon-optimized murine GM-CSF in a murine tumor model","volume":"34","author":"Lin","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.007_b0145","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1016\/j.vaccine.2008.03.060","article-title":"Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus","volume":"26","author":"Muthumani","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.007_b0150","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/infdis\/jiu114","article-title":"DNA vaccine initiates replication of live attenuated Chikungunya virus in vitro and elicits protective immune response in mice","volume":"209","author":"Tretyakova","year":"2014","journal-title":"J Inf Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17313713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17313713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T15:54:06Z","timestamp":1603122846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17313713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":30,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0264410X17313713"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.007","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and application of a bioluminescent imaging mouse model for Chikungunya virus based on pseudovirus system","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}